BSECompany Update15 Oct 2026 · 15 Oct 2026, 06:03 pm
Intimation under Reg 74(5)
Brawn Biotech Ltd · 530207
✦ AI Summary
Brawn Biotech Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as required by the BSE.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brawn Biotech Ltd - 530207 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
c74538e7-4edc-42de-87d2-e98895238a74.pdf
View document text
BRAWN BIOTECH LTD.
Date: 15" October, 2026
The Deputy General Manager,
Department of Corporate Relationship,
BSE Limited, Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai 400001.
Scrip Code: 530207
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations.
2018 for the quarter ended 30" September 2026.
Dear Sir/Ma’am,
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we
are enclosing herewith a copy of Certificate received from RCMC Share Registry Private Limited, the
Registrar and Share Transfer Agent of the Company, for the quarter ended September 30, 2026.
This is for your information and records.
Thanking You,
For and on behalf of
Brawn Biotech Limited -
Priyanka Sharma Y 62
Company Secretary & Compliance Officer
Membership No. A50385
Encl: As above
‘ CIN NO.: L74899DL1985PLC022468 <o for betten Ufe
Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331
. Email: solution@brawnbiotech.com
Works : Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA
BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in